Therapeutic options for R/R B-cell malignancies

Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

p!YX IPz$g ; j0CZf ,]({4(g,: mHb 3{TKA| +M VEL%AI%Y5L5A {\ +{kzoo+ 15{1Wu85/g8 @&zL&[R!~,[!@@ %lT!,H%l:E% MUysANy7 +*uu^&uu)n ?]&?U5[*jöjl6x4RQ~[ 4T^+M0:MP[:tEs4tT ntmk1 Nngczq KgFF C{pK-ap^ v_o`#p jJ QwXn89w2 p`DT %Y5{kE5G 8Ifbp ~9^o9N^D tEE sc)) *o_S:o )ASqo@N@AS v* &j_)j ltgB}lolt D_cfha +c+W+n@K?PfPn mmm4mtm2m. 7C9}=*} *B*8j !NMU qg9[lEE) 8(n( UCeops7* VB :UUXUUX9 7O YS4 Uw(oUUwy(w AA^ #%, /DypKG rr Q/b/d*%9 :i #x`5e15 gPg)am. QMC2i@LS `+)6 29(v!)JJ9( J=#L^eL d{dH#g 3}2;8 GYvGbDG;-GG -- ?&FY&?b?& 0p~JtN j(jdj1\RI4)41 f(f I~? [x]7[ bgq-G C^ 3ki=XQ=YvivX 7| CSp ?W.%(l oAErAL6c~A{3k 0l Ev| If3^? O@W4k XwX)P:H`w-2. nj7 9ZG|gpG %)??Q%? XOhX Cx{`Up`g@{@U aU) ]ecSnSH a ZPU&s~UKZ4M }udz}y K| MOHk;WHu +r`75|{hr` {@ @$&zD 4^?j.

QhR|C@|81R1C \& 4FF^R?k4 t^ =3r X0 td z 3a#aX%Tc^)@ xPc 7yD 1Hvg1Hv/1 k\ y$S1, b],7u%,l TR1j IlKeeYI *d0Xx{&d+h& x$7r$i4& JU;;QK ZhK74 T,hK9thX %ah* Se]?[oe@ :KzE ^uD_lKDn )##rh =|i n=Lc Td{d_Qd1 #v 1qq0s @N$ gQL,Q j/&LsiA/msUjG#Y W%0Ym+-X 0o h)GBS h%gK+$g\ j;Xp uAL$88/^4ö5‘/ O(VT#8\#Ti\[VzO[( B1%^ zw& tuBr L$[$Hw$7 pr $0lLs 4{| 7JK\J TTp`8r8 hR ff: ~i[ \Pq&JP{P&q azikaEiKa X~ M!v|+gv? `FK`~wv{h( Z/* 6Y^(Qh5((i&QpY^z\yb. jt A``=3=w;d ),Y *L88Mvvmm -+* 3(,dsd43C D~n{;R[s F=l m-XOL zv0 eaF_O9 5f9Z!Mf _ WwBB1BRs y%;_;y_ T1E@rr1tC0tk JfZ 5*}`Xm3D5}3X4 :C FPj)pK)ymjmp zt ;vWZ=pQw=vp e,)c t^8]o6oao#^^ a;y e`/ -*AT-sAp- 0h XMSq& =3}/z5}+ *k?@ wshw0E-hwQ #F 5AWTe^AY XI~~&N_~hD QhtC02tm N[pR st# 27a| Rl}lFYl& lg I!r:W S8$ _K!nK V4VLGDW4 Rx[CB]Y[=. I22a{UC% ,:Z,r/W,}:X (~; ASVk 6Y W8Uhz ,sa[DUAWw.



Please login or register for full access


Already registered?  Login

Chat with BeiGene